Molina Healthcare reports Q3 2026 adjusted EPS $0.89, GAAP EPS $0.73; premium revenue $10.46B
Molina Healthcare reported Q3 2026 GAAP EPS of $0.73 and adjusted EPS of $0.89, with total revenue of $11.08B and premium revenue of $10.46B. The company reaffirmed its full-year 2026 guidance. Membership declined to 4.9M, with Medicaid as the largest segment. Cash and investments totaled $4.48B.
How this was made

The 30-second read
Why it matters
This quarter’s EPS and premium revenue, plus the reaffirmed full-year guidance, should influence near-term valuation and estimate revisions, especially around margin sustainability and membership trajectory.
Market read
Traders can update models for managed-care margin and guidance credibility based on the reported EPS, premium revenue, and MCR stability.
What to watch
The article highlights MCR and G&A discipline but does not quantify guidance assumptions or payer mix changes, which can be the real driver of forward estimates.
Background
Molina Healthcare is a US managed care organization with earnings heavily influenced by Medicaid and Marketplace membership levels and medical care ratio (MCR) performance.
Ticker impact
Molina Healthcare reported Q3 2026 adjusted EPS of $0.89 and reaffirmed full-year 2026 guidance for premium revenue and adjusted earnings.
Shares may trade in a range as the print and guidance are digested, with attention on MCR stability and membership declines.
The article provides concrete Q3 EPS/revenue and reiterates full-year premium revenue and adjusted EPS guidance, but it does not state beats/misses versus consensus or any change in outlook.
Market effects
Reinforces the managed-care earnings sensitivity to medical care ratio discipline and Medicaid/Marketplace membership mix.
Limited direct regional spillover; primarily impacts US managed-care sentiment.
Low, as this is a US healthcare payer earnings and guidance update.
Counterpoint
If the market is already positioned for stable MCRs, the membership declines could dominate and pressure the stock despite guidance reaffirmation.
Key entities
- companyMolina Healthcare, Inc.
Reported Q3 2026 GAAP and adjusted EPS, premium revenue, MCR, and reaffirmed full-year 2026 guidance.

